secwatch.observer — SEC 8-K summary
======================================

Issuer:     APTARGROUP, INC. (ATR)
CIK:        0000896622
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0001104659-23-027439
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

AptarGroup appoints Julie Xing as independent director effective March 1, 2023
------------------------------------------------------------------------------

- Julie Xing, 54, appointed to AptarGroup board effective March 1, 2023; term expires at 2023 annual meeting.
- Xing is independent under NYSE rules; committee assignments not yet determined.
- She serves as Executive Chair of Mundipharma (China) and Board Advisor to Mars; over 20 years in pharma/medtech.
- Compensation will match other non-employee directors as described in 2022 proxy statement.
- No arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896622/000110465923027439/0001104659-23-027439-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896622/000110465923027439/tm238217d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-027439

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer